S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)

Jonestrading Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Jonestrading. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Jonestrading.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
ALRN
Aileron Therapeutics
11/25/2021Reiterated byJonestradingBuy $5.00High
BOLT
Bolt Biotherapeutics
11/24/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $45.00High
DCPH
Deciphera Pharmaceuticals
11/22/2021Reiterated byJonestradingSellHigh
MITT
AG Mortgage Investment Trust
11/19/2021Target Lowered byJonestradingBuy$16.00 -> $14.50Low
LABP
Landos Biopharma
11/15/2021Downgraded byJonestradingAnalyst Prakhar AgrawalBuy -> HoldMedium
CBIO
Catalyst Biosciences
11/12/2021Downgraded byJonestradingAnalyst Soumit RoyBuy -> HoldHigh
ARR
ARMOUR Residential REIT
10/28/2021Downgraded byJonestradingBuy -> HoldLow
AY
Atlantica Sustainable Infrastructure
10/11/2021Initiated byJonestradingBuy $46.00Low
TGP
Teekay LNG Partners
10/4/2021Downgraded byJonestradingBuy -> HoldLow
AMYT
Amryt Pharma
10/4/2021Initiated byJonestradingBuy $45.00Low
FLMN
Falcon Minerals
10/1/2021Reiterated byJonestradingBuy $11.00High
BOLT
Bolt Biotherapeutics
9/24/2021Initiated byJonestradingAnalyst Soumit RoyBuy $45.00Low
LABP
Landos Biopharma
9/23/2021Initiated byJonestradingBuy $39.00Low
SBTX
Silverback Therapeutics
9/16/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $50.00High
CRNX
Crinetics Pharmaceuticals
9/16/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $45.00Low
ADAP
Adaptimmune Therapeutics
9/13/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $15.00Low
CBIO
Catalyst Biosciences
9/10/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $18.00Medium
ORC
Orchid Island Capital
9/10/2021Upgraded byJonestradingSell -> HoldLow
ADAP
Adaptimmune Therapeutics
9/7/2021Reiterated byJonestradingBuy $15.00High
SAVA
Cassava Sciences
9/3/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $215.00High
APTS
Preferred Apartment Communities
8/27/2021Target Raised byJonestradingBuy$11.00 -> $13.50Medium
SAVA
Cassava Sciences
8/25/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $215.00High
SBTX
Silverback Therapeutics
8/24/2021Reiterated byJonestradingBuy $50.00High
ACET
Adicet Bio
8/24/2021Reiterated byJonestradingBuy $33.00Low
CLLS
Cellectis
8/20/2021Reiterated byJonestradingBuy $30.00Medium
CYAD
Celyad Oncology
8/20/2021Reiterated byJonestradingHoldHigh
BPMP
BP Midstream Partners
8/10/2021Downgraded byJonestradingBuy -> HoldLow
CBIO
Catalyst Biosciences
8/9/2021Initiated byJonestradingAnalyst Soumit RoyBuy $18.00Low
LUMO
Lumos Pharma
8/6/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $25.00Low
KZR
Kezar Life Sciences
7/20/2021Initiated byJonestradingBuy $14.00Medium
IKT
Inhibikase Therapeutics
7/15/2021Initiated byJonestradingBuy $12.00High
FEMY
Femasys
7/13/2021Initiated byJonestradingBuy $8.45High
KRYS
Krystal Biotech
7/2/2021Reiterated byJonestradingAnalyst Lina KaminskiBuy $97.00Low
LIFE
aTyr Pharma
6/30/2021Reiterated byJonestradingAnalyst Prakhar AgrawalBuy $15.00Low
CBAY
CymaBay Therapeutics
6/21/2021Reiterated byJonestradingBuy $8.00Medium
AVXL
Anavex Life Sciences
6/14/2021Reiterated byJonestradingBuy $35.00High
CBAY
CymaBay Therapeutics
6/14/2021Initiated byJonestradingBuy $8.00Medium
AM
Antero Midstream
6/8/2021Downgraded byJonestradingBuy -> HoldMedium
SURF
Surface Oncology
6/4/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $18.00High
MITT
AG Mortgage Investment Trust
5/25/2021Initiated byJonestradingBuy $15.00Low
LIFE
aTyr Pharma
5/18/2021Initiated byJonestradingBuy $15.00High
AAIC
Arlington Asset Investment
5/17/2021Target Raised byJonestradingBuy$4.00 -> $5.00N/A
AAIC
Arlington Asset Investment
5/10/2021Target Raised byJonestradingBuy$4.00 -> $5.00N/A
ACET
Adicet Bio
5/5/2021Initiated byJonestradingBuy $33.00N/A
CRNX
Crinetics Pharmaceuticals
5/3/2021Initiated byJonestradingBuy $42.00Medium
ACET
Adicet Bio
4/29/2021Initiated byJonestradingBuy $33.00N/A
TRIL
Trillium Therapeutics
4/26/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $25.00Medium
ARR
ARMOUR Residential REIT
4/23/2021Target Raised byJonestradingBuy$11.00 -> $13.00Medium
NRZ
New Residential Investment
4/21/2021Reiterated byJonestradingBuy -> HoldN/A
ORC
Orchid Island Capital
4/21/2021Reiterated byJonestradingHold -> Sell$6.00 -> $4.75N/A
ORC
Orchid Island Capital
4/15/2021Downgraded byJonestradingHold -> Sell$6.00 -> $4.75High
NRZ
New Residential Investment
4/15/2021Downgraded byJonestradingBuy -> HoldMedium
LUMO
Lumos Pharma
4/13/2021Initiated byJonestradingBuy $34.00High
CMRX
Chimerix
4/12/2021Reiterated byJonestradingBuy $14.00High
SURF
Surface Oncology
4/11/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $18.00High
TCON
TRACON Pharmaceuticals
4/1/2021Initiated byJonestradingBuyLow
CYAD
Celyad Oncology
3/31/2021Reiterated byJonestradingBuy -> HoldLow
OCUP
Ocuphire Pharma
3/29/2021Initiated byJonestradingBuy $20.00High
CYAD
Celyad Oncology
3/25/2021Downgraded byJonestradingBuy -> HoldMedium
SAVA
Cassava Sciences
3/23/2021Reiterated byJonestradingBuyHigh
TRIL
Trillium Therapeutics
3/19/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $25.00Medium
DTIL
Precision BioSciences
3/18/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $27.00High
SYBX
Synlogic
3/18/2021Initiated byJonestradingBuy $15.00High
CRIS
Curis
3/17/2021Target Raised byJonestradingBuy$14.00 -> $18.00High
SAVA
Cassava Sciences
3/17/2021Initiated byJonestradingBuyHigh
HAFC
Hanmi Financial
3/11/2021Initiated byJonestradingBuy $24.00Medium
EQ
Equillium
3/3/2021Initiated byJonestradingBuy $14.00Medium
ARNA
Arena Pharmaceuticals
3/3/2021Target Lowered byJonestradingAverage -> Buy$101.00 -> $94.00High
DTIL
Precision BioSciences
2/24/2021Initiated byJonestradingBuy $27.00Low
APTO
Aptose Biosciences
2/22/2021Initiated byJonestradingBuy $14.00High
KRYS
Krystal Biotech
2/9/2021Initiated byJonestradingBuy $97.00Low
DYN
Dyne Therapeutics
2/9/2021Initiated byJonestradingBuyLow
LFT
Lument Finance Trust
2/5/2021Initiated byJonestradingBuy $4.50N/A
DX
Dynex Capital
2/5/2021Target Raised byJonestradingBuy$18.50 -> $19.00Medium
PHAT
Phathom Pharmaceuticals
1/28/2021Initiated byJonestradingBuyMedium
ARQT
Arcutis Biotherapeutics
1/28/2021Initiated byJonestradingBuyHigh
ARNA
Arena Pharmaceuticals
1/28/2021Initiated byJonestradingBuyHigh
TTOO
T2 Biosystems
1/27/2021Reiterated byJonestradingAnalyst Soumit RoyBuy $3.50High
ORC
Orchid Island Capital
1/15/2021Target Raised byJonestradingBuy$5.50 -> $6.00Low
APTS
Preferred Apartment Communities
1/12/2021Initiated byJonestradingBuy $11.00Low
CMRX
Chimerix
1/8/2021Reiterated byJonestradingBuy $10.00High

MarketBeat Community Rating for Jonestrading

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  57
MarketBeat's community ratings are surveys of what our community members think about Jonestrading and other research firms. Vote "Outperform" if you believe Jonestrading's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Jonestrading's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.